Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This phase III study is designed as a double blind, randomized, multi-nation, multi-center, placebo controlled clinical research, which aims to evaluate the safety and efficacy of Dantonic® (T89) in patients with chronic stable angina pectoris.
Epistemonikos ID: 0c034b31f5d3d6a6e9d2b5a248de732884fdda5b
First added on: May 11, 2024